back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-16 16:23 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
700,000 | |
| Filed 2022-08-12 16:18 Tx date 2022-08-10 |
$AVCR
Avricore Health Inc. |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
500,000 | |
| Filed 2021-08-17 11:47 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,500
-180,000 vol $0.175 each |
620,000 | |
| Filed 2021-08-16 17:56 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,500
-500,000 vol $0.175 each |
||
| Filed 2021-08-16 17:56 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,500
-500,000 vol $0.175 each |
300,000 | |
| Filed 2021-08-16 17:50 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$75,000
+500,000 vol $0.15 each |
800,000 | |
| Filed 2021-08-16 17:37 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-75,000
-500,000 vol $0.15 each |
0 | |
| Filed 2021-08-16 17:06 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-500,000 vol |
||
| Filed 2021-04-19 22:02 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
375,000 | |
| Filed 2021-04-19 21:45 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
||
| Filed 2021-04-19 21:45 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
375,000 | |
| Filed 2021-02-11 00:07 Tx date 2021-02-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,275
-69,500 vol $0.45 each |
300,000 | |
| Filed 2021-01-29 18:41 Tx date 2020-11-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,500
-100,000 vol $0.085 each |
400,000 | |
| Filed 2021-01-29 18:36 Tx date 2021-01-25 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,930
-30,500 vol $0.26 each |
369,500 |